Smith & Nephew (SNN) Net Equity Issued and Repurchased (2009 - 2023)

Smith & Nephew (SNN) posted quarterly Net Equity Issued and Repurchased of $1.0 million for Q4 2023, down 75.0% on a QoQ basis from $4.0 million in Q4 2021.

Smith & Nephew (SNN) Net Equity Issued and Repurchased (2009 - 2023) Analysis & Trends

Smith & Nephew (SNN) has reported Net Equity Issued and Repurchased for 14 consecutive years, with $1.0 million the latest figure, recorded in Q4 2023.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $1.0 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $9.0 million (changed N/A YoY) and the FY2025 annual result came in at $12.0 million, up 1100.0% from the prior year.
  • Net Equity Issued and Repurchased declined to $1.0 million in Q4 2023 per SNN's latest filing, from $4.0 million in the prior quarter.
  • Over the last five years, Net Equity Issued and Repurchased for SNN reached as high as $4.0 million in Q4 2021 and fell as low as $1.0 million in Q4 2023.
  • A 4-year average of $2.2 million and a median of $2.0 million in 2019 frame the typical range for Net Equity Issued and Repurchased.
  • Annual changes were most pronounced in 2019 — Net Equity Issued and Repurchased sank 80.0% — and 2021, when it soared 100.0%.
  • Year by year, Net Equity Issued and Repurchased stood at $2.0 million in 2019, then changed by 0.0% to $2.0 million in 2020, then surged by 100.0% to $4.0 million in 2021, then tumbled by 75.0% to $1.0 million in 2023.
  • According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $1.0 million, $4.0 million, and $2.0 million for Q4 2023, Q4 2021, and Q4 2020 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 97.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 12.70 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Steris 20.59 Bn 20.16 Bn 697.10 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 1.00 Mn
Dec 31, 2023 1.00 Mn
Dec 31, 2021 4.00 Mn
Dec 31, 2021 4.00 Mn
Dec 31, 2020 2.00 Mn
Dec 31, 2020 2.00 Mn
Dec 31, 2019 2.00 Mn
Dec 31, 2019 2.00 Mn
Dec 31, 2018 10.00 Mn
Dec 31, 2018 10.00 Mn
Dec 31, 2017 5.00 Mn
Dec 31, 2017 5.00 Mn
Dec 31, 2016 1.00 Mn
Dec 31, 2016 1.00 Mn
Dec 31, 2015 1.00 Mn
Dec 31, 2015 1.00 Mn
Dec 31, 2014 24.00 Mn
Dec 31, 2014 24.00 Mn
Sep 30, 2014 8.00 Mn
Sep 30, 2014 8.00 Mn